Interpace OTC Stock Volatility


USD 1.43  0.12  7.74%   

Interpace Biosciences holds Efficiency (Sharpe) Ratio of -0.0626, which attests that the entity had -0.0626% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Interpace Biosciences exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Interpace Biosciences market risk adjusted performance of (0.38), and Risk Adjusted Performance of (0.018032) to validate the risk estimate we provide.
Interpace Biosciences OTC Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Interpace daily returns, and it is calculated using variance and standard deviation. We also use Interpace's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Interpace Biosciences volatility.

690 Days Market Risk

Extremely Dangerous

Chance of Distress


690 Days Economic Sensitivity

Slowly supersedes the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Interpace Biosciences can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Interpace Biosciences at lower prices. For example, an investor can purchase Interpace stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Interpace Biosciences' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving against Interpace Biosciences

-0.76MRKMerck CompanyPairCorr
-0.71XOMExxon Mobil CorpPairCorr
-0.68CVXChevron CorpPairCorr
-0.66JNJJohnson JohnsonPairCorr
-0.66IBMInternational BusinessPairCorr

Interpace Biosciences Market Sensitivity And Downside Risk

Interpace Biosciences' beta coefficient measures the volatility of Interpace otc stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Interpace otc stock's returns against your selected market. In other words, Interpace Biosciences's beta of 0.39 provides an investor with an approximation of how much risk Interpace Biosciences otc stock can potentially add to one of your existing portfolios.
Interpace Biosciences is displaying above-average volatility over the selected time horizon. Investors should scrutinize Interpace Biosciences independently to ensure intended market timing strategies are aligned with expectations about Interpace Biosciences volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Interpace Biosciences' otc stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Interpace Biosciences' otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
3 Months Beta |Analyze Interpace Biosciences Demand Trend
Check current 90 days Interpace Biosciences correlation with market (NYSE Composite)

Interpace Beta

Interpace standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

It is essential to understand the difference between upside risk (as represented by Interpace Biosciences's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Interpace Biosciences' daily returns or price. Since the actual investment returns on holding a position in interpace otc stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Interpace Biosciences.

Interpace Biosciences OTC Stock Volatility Analysis

Volatility refers to the frequency at which Interpace Biosciences otc price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Interpace Biosciences' price changes. Investors will then calculate the volatility of Interpace Biosciences' otc stock to predict their future moves. A otc that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A otc stock with relatively stable price changes has low volatility. A highly volatile otc is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Interpace Biosciences' volatility:

Historical Volatility

This type of otc volatility measures Interpace Biosciences' fluctuations based on previous trends. It's commonly used to predict Interpace Biosciences' future behavior based on its past. However, it cannot conclusively determine the future direction of the otc stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Interpace Biosciences' current market price. This means that the otc will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Interpace Biosciences' to be redeemed at a future date.
The output start index for this execution was zero with a total number of output elements of sixty-one. Interpace Biosciences Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Interpace Biosciences Projected Return Density Against Market

Given the investment horizon of 90 days Interpace Biosciences has a beta of 0.3932 . This usually indicates as returns on the market go up, Interpace Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Interpace Biosciences will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Interpace Biosciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Interpace Biosciences' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Interpace otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Interpace Biosciences is significantly underperforming NYSE Composite.
   Predicted Return Density   
Interpace Biosciences' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how interpace otc stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Interpace Biosciences Price Volatility?

Several factors can influence a OTC's stock volatility:


Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Interpace Biosciences OTC Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Interpace Biosciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Interpace Biosciences' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Interpace otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Given the investment horizon of 90 days the coefficient of variation of Interpace Biosciences is -1598.58. The daily returns are distributed with a variance of 56.82 and standard deviation of 7.54. The mean deviation of Interpace Biosciences is currently at 5.46. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 1.49
Alpha over NYSE Composite
Beta against NYSE Composite0.39
Overall volatility
Information ratio -0.03

Interpace Biosciences OTC Stock Return Volatility

Interpace Biosciences historical daily return volatility represents how much of Interpace Biosciences otc's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 7.5379% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 1.5072% volatility on return distribution over the 90 days horizon.
 Performance (%) 

About Interpace Biosciences Volatility

Volatility is a rate at which the price of Interpace Biosciences or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Interpace Biosciences may increase or decrease. In other words, similar to Interpace's beta indicator, it measures the risk of Interpace Biosciences and helps estimate the fluctuations that may happen in a short period of time. So if prices of Interpace Biosciences fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2022
Market Capitalization31.2 M33.2 M

Interpace Biosciences Investment Opportunity

Interpace Biosciences has a volatility of 7.54 and is 4.99 times more volatile than NYSE Composite. 65  of all equities and portfolios are less risky than Interpace Biosciences. Compared to the overall equity markets, volatility of historical daily returns of Interpace Biosciences is higher than 65 () of all global equities and portfolios over the last 90 days. Use Interpace Biosciences to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The otc stock experiences a very speculative downward sentiment. The market maybe over-reacting. Check odds of Interpace Biosciences to be traded at $1.3585 in 90 days.

Significant diversification

The correlation between Interpace Biosciences and NYA is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Interpace Biosciences and NYA in the same portfolio, assuming nothing else is changed.

Interpace Biosciences Additional Risk Indicators

The analysis of Interpace Biosciences' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Interpace Biosciences' investment and either accepting that risk or mitigating it. Along with some common measures of Interpace Biosciences otc stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential otc stocks, we recommend comparing similar otcs with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Interpace Biosciences Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Interpace Biosciences as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Interpace Biosciences' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Interpace Biosciences' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Interpace Biosciences.
Please see Risk vs Return Analysis. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for analysis

When running Interpace Biosciences price analysis, check to measure Interpace Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpace Biosciences is operating at the current time. Most of Interpace Biosciences' value examination focuses on studying past and present price action to predict the probability of Interpace Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Interpace Biosciences' price. Additionally, you may evaluate how the addition of Interpace Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Please note, there is a significant difference between Interpace Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Interpace Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpace Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.